Adenosine accumulates to high levels in inflamed or ischemic tissues and activates A 3 adenosine receptors (ARs) on mast cells to trigger degranulation. Here we show that stimulation of rat basophilic leukemia (RBL)-2H3 mast-like cells with the A 3 AR agonists N 6 -(3-iodo)benzyl-5Ј-N-methylcarboxamidodoadenosine (IB-MECA; 10 nM) or inosine (10 M) stimulates phosphorylation of protein kinase B (Akt). IB-MECA (1 M) also causes a Ͼ50% reduction in apoptosis caused by exposure of RBL-2H3 cells to UV light. Akt phosphorylation is not stimulated by 100 nM N 6 -cyclopentyladenosine (A 1 -selective) or CGS21680 (A 2A -selective) and is absent in cells pretreated with wortmannin or pertussis toxin. The K I values of the AR antagonists BW-1433 and 8-sulfophenyltheophylline (8-SPT) were determined in radioligand binding assays for all four subtypes of rat ARs: BW-1433 (A 1 , 5.8 Ϯ 1.0 nM; A 2A , 240 Ϯ 37; A 2B , 30 Ϯ 10; A 3 , 12,300 Ϯ 3,700); 8-SPT (A 1 , 3.2 Ϯ 1.2 M; A 2A , 57 Ϯ 4; A 2B , 2.2 Ϯ 0.8; A 3 , Ͼ100). BW-1433 and the A 3 -slective antagonist MRS1523 (5 M), but not 8-SPT (100 M), block IB-MECA-induced protection from apoptosis, confirming the A 3 AR as the mediator of the antiapoptotic response. The data suggest that adenosine and inosine activate Gi-coupled A 3 ARs to protect mast cells from apoptosis by a pathway involving the ␤␥ subunits of Gi, phosphatidylinositol 3-kinase ␤, and Akt. We speculate that activation of A 3 ARs on mast cells or other cells that express A 3 ARs (e.g., eosinophils) may facilitate their survival and accumulation in inflamed tissues.
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Activation of the serine/threonine kinase, Akt, also called protein kinase B (PKB) inhibits programmed cell death Kandel et al., 1999; Stambolic et al., 1999) . Phosphoinositides generated by activated phosphatidylinositol 3-kinases (PI3Ks) bind to the plextrin homology domain on Akt and stimulate its translocation to the plasma membrane, where it is phosphorylated on both Ser473 and Thr308 and activated by phosphoinositide-dependent kinase-1 . PI3Ks can be activated by tyrosine kinase growth factor receptors, or in some cells by activation of G protein-coupled receptors. Activation of PI3K via heterotrimeric G proteins occurs selectively in cells that express PI3K␤ (Murga et al., 2000) . Hence, it is possible that Akt is involved in the regulation of apoptosis that has been noted in astrocytes and cardiomyocytes by G protein-coupled A 3 ARs . The A 3 AR is known to regulate the degranulation of rodent perivascular mast cells and RBL-2H3 mast-like cultured cells (Ramkumar et al., 1993) . Activation of mast cell A 3 ARs increases mast cell degranulation to release histamine and other allergic mediators. This prompted us to determine in this study whether A 3 AR activation protects RBL-2H3 mast cells from apoptosis. We show that IB-MECA, Cl-IB-MECA, and inosine signal via A 3 ARs to stimulate phosphorylation of Akt and to reduce RBL-2H3 cell apoptosis induced by UV light.
Experimental Procedures
Materials. CPA, 5Ј-N-ethylcarboxamidoadenosine, Cl-IB-MECA, CGS21680, 8-SPT, theophylline, and enprofylline were purchased This work was supported by Grant R01-HL37942 from the National Institutes of Health.
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ABBREVIATIONS:
Akt or PKB, protein kinase B; PI3K, phosphatidylinositol 3-kinases; AR, adenosine receptor; RBL, rat basophilic leukemia; IB-MECA, N 6 -(3-iodobenzyl)-5Ј-N-methylcarboxamidoadenosine; CPA, N 6 -cyclopentyladenosine; CGS21680, 2-p-(2-carboxyethyl)phenethylamino-5Ј-ethylcarboxaminoadenosine; 8-SPT, 8-sulfophenyltheophylline; enprofylline, 3-propylxanthine; MRS1523, 5-propyl 2-ethyl-4-propyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate; WRC-0571, C from RBI/Sigma (Natick, MA). MRS1523 was a gift from Dr. K.A. Jacobson (National Institutes of Health, Bethesda, MD). IB-MECA was obtained from Dr. Saul Kadin (Pfizer, Groton, CT), and WRC-0571 was obtained from Dr. Pauline Martin (Discovery Therapeutics, Richmond, VA). BW-1433, 3-(4-amino-3-iodobenzyl)-8-oxyacetate-1-propyl-xanthine and N 6 -aminobenzyladenosine (ABA) were from Dr. Susan Daluge (Glaxo-Wellcome, Research Triangle Park, NC). Wortmannin was from Calbiochem (San Diego, CA); pertussis toxin was from Sigma Chemical Co. (St. Louis, MO); adenosine deaminase was from Boehringer-Mannheim Biochemicals (Indianapolis, IN); cell culture medium was from Life Technologies (Gaithersburg, MD); phospho-AKT (Ser473 or Thr308) antibodies were from New England BioLabs (Beverly, MA); and polyclonal anti-AKT antibody was a gift from Dr. John C. Lawrence (University of Virginia, Charlottesville, VA).
Cell Culture. Rat basophilic leukemia 2H3 clonal cells (RBL-2H3) were from Dr. R.P. Siraganian (National Institutes of Health, Bethesda, MD) and were grown as monolayers in Eagle's minimum essential medium with Earle's balanced salts without glutamine, supplemented with 10% fetal calf serum, 200 mM glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 50 g/ml gentamicin, and 25 g/ml fungizone. Cells were subcultured every 3 days.
Radioligand Binding Studies. Rat A 2B receptor cDNA was prepared by reverse transcription polymerase chain reaction from rat bladder and sequenced on both strands in the University of Virginia Biomolecular core laboratory. The A 2B cDNA was subcloned into pDoubleTrouble (Robeva et al., 1996) . The plasmids were amplified in competent JM109 cells and plasmid DNA isolated using Wizard Megaprep columns (Promega Corporation, Madison, WI). Rat A 2B and A 3 cDNAs were introduced into HEK-293 cells by means of Lipofectin. Stable clones were selected using 500 g/ml G418 (Life Technologies) and maintained in 250 g/ml G418. HEK-293T cells were transiently transfected with rat A 2A ARs. HEK-293 cells expressing recombinant receptors or rat cortex (a rich source of A 1 receptors) were homogenized in HE buffer (10 mM HEPES, 1 mM EDTA, pH 7.4) with protease inhibitors (10 g/ml benzamidine, 100 M phenylmethylsulfonyl fluoride, and 2 g/ml each of aprotinin, pepstatin, and leupeptin). The membranes were homogenized in a Polytron Homogenizer (Brinkmann Instruments, Westbury, NY) for 20 s, centrifuged at 30,000g, and the pellets washed twice in HE buffer with protease inhibitors. The final pellet was resuspended in HE supplemented with 10% sucrose and frozen in aliquots at Ϫ80°C. For binding assays, membranes were thawed and diluted 5-to 10-fold with HE to a final membrane protein concentration of approximately 1 mg/ml. Saturation binding assays for rat adenosine receptors were performed, respectively, with 125 I-ABA for A 1 and A 3 ARs (Linden et al., 1985; Salvatore et al., 1993) , 125 I-ZM241385 for A 2A AR (Sullivan et al., 1999) , and [ 125 I]3-(4-amino-3-iodobenzyl)-8-oxyacetate-1-propylxanthine for A 2B AR . Nonspecific binding was defined using 100 M 5Ј-N-ethylcarboxamidoadenosine. Radioligand binding experiments were performed in triplicate with 10 to 25 g of membrane protein in a total volume of 0.1 ml HE buffer supplemented with 1 U/ml adenosine deaminase and 5 mM MgCl 2 . The incubation time was 3 h at 21°C. Competition experiments were carried out using 0.5 to 1 nM radioligands and seven concentrations of competing ligands. Membranes were filtered on Whatman GF/C filters using a Brandel cell harvester (Gaithersburg, MD) and washed three times over 15 to 20 s with ice-cold buffer (10 mM Tris, 1 mM MgCl 2 , pH 7.4). K I values were derived from IC 50 values of competition binding assays as described previously (Linden, 1982) .
Akt/PKB Phosphorylation Assay. RBL-2H3 cells were serumstarved for 18 h and AKT activation assays were carried out on monolayers of cells in serum-free Eagle's minimal essential medium in a 37°C, 5% CO 2 incubator. The reactions were terminated by placing the cells on ice and washing them with ice-cold PBS. Cells were then lysed in Triton lysis buffer [50 mM Tris⅐HCl, pH 7.5, 100 mM NaCl, 50 mM NaF, 5 mM EDTA, 1% (v/v) Triton X-100, 40 mM ␤-glycerophosphate, 40 mM paranitrophenylphosphate, 200 M sodium orthovanadate, 100 M phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml pepstatin A, and 1 g/ml aprotinin]. The lysate was mixed and clarified by centrifugation (15 min, 14,000 rpm, 4°C) in an Eppendorf microcentrifuge. The supernatant was subjected to SDS-polyacrylamide gel electrophoresis followed by transfer to nitrocellulose and immunoblotting. Phosphorylation and activation of PKB was detected by immunoblotting using rabbit polyclonal antiphospho-Akt (Ser473 or Thr308) antibody and visualized by enhanced chemiluminescence with horseradish peroxidase conjugated goat anti-rabbit IgG as the secondary antibody (1:10,000 dilution). The membranes were then stripped by incubating in stripping buffer (62.5 mM Tris⅐HCl, 2% SDS, and 100 mM ␤-mercaptoethanol, pH 6.7 at 65°C) in a shaking water bath, and reprobed with polyclonal anti-PKB antibodies to quantify the total PKB loaded onto each lane.
Apoptosis Assay. Protection from UV-induced apoptosis was carried out essentially as described previously (Murga et al., 1998) . Cells were starved overnight in Eagle's minimal essential medium containing 10 mM HEPES. Subsequently, starved cells were subjected to UV irradiation (150 mJ; UV-Stratalinker 2400; Stratagene, La Jolla, CA). After UV treatment, fresh serum-free medium with and without test compounds was added to cells and they were maintained in the incubator for an additional 10 h. The cells were fixed in 4% paraformaldehyde and apoptotic cells were detected by terminal deoxynucleotidyltransferase-mediated dUTP-fluorescein isothiocyanate nick end labeling (TUNEL), following the manufacturer's instructions (Boehringer Mannheim). The frequency of apoptosis was scored by counting several hundred positive TUNEL-stained cells from 25 different fields per coverslip. Results from four independent experiments are reported as the mean Ϯ S.E.M.
Results
IB-MECA activates A 3 ARs to degranulate RBL-2H3 cells half-maximally at a concentration of 4.2 nM . To study the influence of A 3 AR activation on Akt phosphorylation, we initially used a concentration of IB-MECA (100 nM) sufficient to trigger maximal mast cell degranulation. Activation of Akt requires phosphorylation of both Ser473 in the C-terminal regulatory domain and Thr308 in the activation loop of the kinase domain. We initially used the specific anti-phospho(Ser473)-Akt antibody to study the regulation of Akt phosphorylation by A 3 AR. Subsequent studies using the specific anti-phospho(Thr308)-Akt antibody yielded essentially the same results. For simplicity, we report hereafter only the results from the experiments using anti-phospho(Ser473) antibody. IB-MECA significantly stimulated Akt phosphorylation within 2 min, and the response peaked in 5 min (Fig. 1A) . The dose-dependence of IB-MECA to stimulate Akt phosphorylation at 5 min is shown in Fig. 1B . Maximal Akt phosphorylation was produced by 100 nM IB-MECA. Similar results were obtained with another A 3 ARselective agonist, Cl-IB-MECA (data not shown). The addition of 100 nM CPA, an A 1 AR-selective agonist, or 100 nM CGS21680, an A 2A AR-selective agonist, failed to significantly stimulate Akt phosphorylation (Fig. 2A) ; inosine, however, a weak but selective agonist of rat A 3 ARs, did stimulate Akt phosphorylation in the range of 10 to 100 M (Fig. 2B) . Xanthines are weak antagonists of rodent A 3 ARs. However, the nonselective xanthine antagonist BW-1433 blocks the rat A 3 AR with a K I value of approximately 20 M . As shown in Fig. 2 , B and C, BW-1433 reduced IB-MECA-stimulated Akt phosphorylation in a dose-dependent manner, but concentrations of WRC-0571, ZM241385, theophylline, enprofylline, and 8-SPT sufficient to block A 1 , A 2A , or A 2B receptors singly or in combination failed to block Akt phosphorylation (Fig. 2B) . Furthermore, a selective antagonist of the rat A 3 receptor, MRS1523 (5 M) also blocked IB-MECA-induced Akt phosphorylation. Therefore, we conclude that the A 3 AR subtype is responsible for IB-MECAmediated stimulation of Akt phosphorylation in RBL-2H3 cells.
We next sought to examine the signaling pathway by which A 3 AR activation triggers Akt phosphorylation. Pretreatment of RBL-2H3 cells with 100 ng/ml pertussis toxin for 6 h nearly abolished IB-MECA-induced Akt phosphorylation (Fig. 3A) . Pretreatment of cells for 30 min with 10 nM wortmannin, an inhibitor of PI3Ks, abolished IB-MECA-induced Akt phosphorylation (Fig. 3B) . These data suggest that the A 3 AR signals through a pathway including Gi/o and PI3K. To determine whether A 3 AR activation inhibits programmed cell death in RBL-2H3 cells, apoptosis was stimulated by exposing cells to UV light. As shown in Fig. 4 , 100 nM IB-MECA failed to significantly reduce UV light-induced apoptosis, but 1 or 10 M IB-MECA reduced apoptosis by more than 50%. Comparable results were also obtained with Cl-IB-MECA (data not shown). At concentrations Յ 10 M, IB-MECA alone (in the absence of UV treatment) did not cause any change in apoptosis in RBL-2H3 cells. However, 100 M IB-MECA did induce apoptosis (20ϳ25% above control) in RBL-2H3 cells by unknown mechanisms (data not shown). This is consistent with the data published previously showing that high concentrations of IB-MECA (Ͼ10 M) induce apoptosis in various cell types Shneyvays et al., 1998) . The greater potency of IB-MECA in stimulating Akt phosphorylation (Fig. 1B) than in inhibiting apoptosis (Fig. 4) may be related to the time courses of the two assays, (minutes for the phosphorylation assay versus hours for the apoptosis assay) because A 3 receptors have been shown to undergo rapid desensitization (Palmer and Stiles, 2000) . Alternatively, activation of Akt alone may not be sufficient to inhibit apoptosis, and higher concentrations of IB-MECA may activate additional anti-apoptotic pathways.
To ensure that the protection from apoptosis caused by IB-MECA is mediated by A 3 ARs, we compared the effects of BW-1433, a xanthine that has been reported to block all rat ARs including the A 3 AR , with 8-SPT, a xanthine that is thought to block all subtypes of rat ARs except A 3 (Fozard et al., 1996) . As shown in Fig. 5A and B, BW-1433 (100 M) but not 8-SPT (100 M) reversed the ability of 10 M IB-MECA to reduce apoptosis, suggesting the involvement of A 3 ARs in the IB-MECA-mediated antiapoptotic effect. To further confirm this pharmacology, we determined the K I values of these two xanthines for the four subtypes of rat adenosine receptors (Table 1) . The data confirm that at 100 M BW-1433 effectively blocks all four subtypes, whereas 100 M 8-SPT blocks rat A 1 , A 2A , and A 2B , but only weakly blocks rat A 3 ARs. Furthermore, the effect of 10 M IB-MECA in reducing apoptosis was also blocked by the A 3 -selective antagonist MRS1523 in a dose-dependent manner (Fig. 5C) . In radioligand binding studies (Fig. 6) , we determined that the affinity of MRS1523 for rat A 3 AR is 519 Ϯ 86 nM (mean Ϯ S.E.M., N ϭ 6). This K I value is somewhat higher (ϳ5-fold) than the K I value (113 nM) reported by Li et al. (1998) , but it is consistent with our observation that 5 M MRS1523 almost completely blocked the effect of IB-MECA on apoptosis in RBL-2H3 cells, whereas 1 M MRS1523 had only a small effect. Collectively, these data suggest that the antiapoptotic effect of IB-MECA is mediated by A 3 ARs.
We evaluated the effect of wortmannin on the antiapoptotic effect of IB-MECA. As is the case for IB-MECA-induced Akt phosphorylation, the IB-MECA-induced inhibition of apoptosis is reversed by pretreatment of RBL-2H3 cells with 10 or 50 nM wortmannin (Fig. 5 C) . This suggests that PI3K is involved in A 3 AR-mediated inhibition of apoptosis in RBL-2H3 cells.
Discussion
Adenosine and various adenosine analogs have been reported to both stimulate and inhibit apoptosis in various cells . In human mononuclear cells, apoptosis is stimulated by adenosine analogs through activation of A 2A or A 3 receptors or by non-receptor-mediated effects of intracellular nucleosides (Barbieri et al., 1998) . In cultured newborn rat cardiomyocytes, high concentrations of IB-MECA trigger apoptosis Shneyvays et al., 1998) . In cells of astroglial lineage, apoptosis is stimulated by high concentrations of IB-MECA and inhibited by low concentrations (Franceschi et al., 1996) . In this study, we set out to investigate possible A 3 AR-mediated effects on programmed cell death in RBL 2H3 cells, a line in which the existence of functional A 3 ARs has been firmly established (Ramkumar et al., 1993; Jin et al., 1997) . We also investigated the signaling pathway through which apoptosis is regulated in these cells.
Pharmacology of Adenosine Receptors to Inhibit Apoptosis in RBL-2H3 Cells. Because various adenosine analogs either stimulate or inhibit apoptosis through mechanisms involving different AR subtypes and receptorindependent mechanisms, there is some uncertainty about the mechanism of the effects of IB-MECA on apoptosis in various cells. We reasoned that the effects of A 3 AR receptor activation on apoptosis should be examined using cells in which a physiological effect of A 3 AR activation has been clearly established. In RBL-2H3 cells, we were able to detect Akt activation not only by 10 nM concentrations of the selective A 3 AR agonists IB-MECA and Cl-IB-MECA, but also by inosine in the range of 10 to 100 M, the same range over which inosine activates A 3 receptors. In ischemic tissues, inosine accumulates to concentrations in excess of 10 M, Fig. 3 . A 3 AR-induced AKT phosphorylation is mediated by pertussistoxin (PTX)-sensitive G proteins and wortmannin-sensitive PI-3 kinases. A, IB-MECA-stimulated AKT phosphorylation is abolished by PTX treatment. For the final 6 h of serum starvation, RBL-2H3 cells were treated with 100 ng/ml PTX before stimulation with 100 nM IB-MECA. B, blockade of IB-MECA-stimulated AKT phosphorylation by the PI-3 kinase inhibitor wortmannin. Serum-starved RBL-2H3 cells were preincubated at 37°C for 30 min with 10 nM wortmannin before stimulation with 100 nM IB-MECA for 5 min. AKT phosphorylation (top) and total AKT (bottom) were determined by immunoblotting. Downloaded from sufficient to selectively activate rat A 3 ARs . Note, however, that inosine is only a weak, partial agonist of human A 3 ARs (X. Jin and J. Linden, unpublished observations). The rat A 3 AR is only weakly blocked by xanthine antagonists or A 3 -selective nonxanthine antagonists of human A 3 ARs (Kim et al., 1996; Baraldi et al., 1999) . MRS1191 (Ͼ1 M) has been reported to compete with radioligands for rat A 3 ARs in binding assays in which solubility is increased by the inclusion of DMSO (Jiang et al., 1997 ), but we found that MRS1191 (10 or 30 M) fails to block IB-MECA effects in intact RBL-2H3 cells at its limits of aqueous solubility (data not shown). MRE308F20 has recently been reported as a potent and selective antagonist of human A 3 receptors (Varani et al., 2000) but this compound does not bind well to A 3 receptors of other species. Hence, in this study, we compared the efficacy of BW-1433 and 8-SPT as evidence that IB-MECA-induced effects on Akt phosphorylation and apoptosis are mediated by A 3 ARs. A similar strategy was used to support the conclusion that A 3 ARs trigger mast cell degranulation in rats (Fozard et al., 1996) . To bolster our conclusions, we determined the K I values of these xanthines in inhibiting radioligand binding to the four subtypes of rat ARs. The binding data indicate that 100 M 8-SPT selectively fails to block rat A 3 ARs, whereas 100 M BW-1433 blocks all rat AR subtypes. Differential blockade by BW-1433 and not by 8-SPT of IB-MECA-induced inhibition of apoptosis is consistent with the conclusion that this effect is mediated by A 3 ARs on RBL-2H3 cells. This conclusion is further supported by the finding that 5 M MRS1523, a recently identified selective antagonist of rat A 3 receptors, blocks the effects of IB-MECA on both Akt phosphorylation and apoptosis in RBL-2H3 cells.
A 3 AR Signaling in RBL 2H3 cells. Recombinant A 3 ARs expressed in HEK-293 cells are coupled to Ca 2ϩ mobilization and inhibition of adenylyl cyclase by a pertussis toxin-sensitive pathway . In this study, we observed that IB-MECA-stimulated Akt phosphorylation is abolished in RBL-2H3 cells treated with pertussis toxin. This is consistent with the conclusion that IB-MECA-mediated Akt phosphorylation involves pertussis-toxin sensitive Gi/o proteins. The pathway may involve the activation of PI3K by G protein ␤␥ subunits (Hawes et al., 1996) . Our observation that wortmannin blocks IB-MECA-induced Akt phosphorylation is consistent with this hypothesis. The PI3Ks consist of a 110-kDa catalytic domain and a regulatory subunit encoded by the p85␣, p85␤, or p55 ␥ genes. In mast cells, phosphorylation of Akt stimulated by activation of Fc⑀RI is blocked by wortmannin (an inhibitor of all classes of PI3Ks), but not by disruption of the p85␣ gene (Lu-Kuo et al., 2000) . This suggests that PI3K␤ could be involved in activation of Akt by Fc⑀RI in mast cells. Murga et al. (2000) have recently suggested that the ␤␥ subunits of heterotrimeric G proteins use PI3K␤ to activate Akt. These considerations suggest that A 3 ARs of RBL 2H3 cells may activate Akt by a pathway including ␤␥ subunits of Gi and PI3K␤. Adenosine Regulation of Apoptosis in Inflammatory Cells. Variability in the expression of PI3K␤ among cells may account for inconsistent effects of A 3 AR activation to influence cell survival. In CHO cells transfected with A 3 ARs, Cl-IB-MECA inhibits cell proliferation, but this effect is not caused by stimulation of apoptosis (Brambilla et al., 2000) . In mice A 3 , ARs are highly expressed in bone marrow-derived mast cells and these receptors play a role in potentiating antigen-dependent degranulation (Salvatore et al., 2000) . In contrast, A 2B rather than A 3 ARs regulate canine BR mast cell and human HMC-1 mast cell function (Auchampach et al., 1997; Linden et al., 1999) . The role of the ␤␥ subunits of heterotrimeric G proteins suggests a possible lesser effect on mast cell survival of A 2B ARs coupled to Gs and Gq than of A 3 ARs coupled to Gi, which is more abundant than Gs or Gq. Additional experiments will be required to determine whether adenosine has a more profound effect on survival of inflammatory cells expressing A 3 ARs than in cells expressing A 2B ARs. There is evidence that A 3 ARs are highly expressed on eosinophils in human lung (Walker et al., 1997) . Eosinophils accumulate in the lungs of patients with asthma and at sites of parasitic invasion. Inhibited apoptosis might contribute to expansion of cells that have A 3 receptors in inflamed tissues. The amount of adenosine required to activate A 3 receptors remains an important question. It is always difficult to estimate the adenosine concentration required to produce any response because of its rapid metabolism. However, Doyle et al. (1994) have shown that 1 M adenosine acting at A 3 receptors produces a mast cell-dependent constriction of isolated microvessels. Hence, we speculate that 1 M adenosine is sufficient to activate A 3 receptors of rat mast cells. Inosine is a partial agonist of the human receptor but a full agonist of the rat receptor . We speculate that this species difference may cause different apoptotic responses to inosine in cells that express rat versus human A 3 receptors. In fact, inosine would be expected to possibly attenuate inhibition of apoptosis in human cells exposed to a combination of adenosine and inosine. Additional experimentation will be necessary to determine whether the accumulation of adenosine and inosine at inflamed sites contributes to inflammatory cell expansion by binding to A 3 ARs to inhibit apoptosis and whether there are species differences in these responses. 
